Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin
Terminated
Mayo Clinic
Phase 2/Phase 3
2005-06-01
The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo
(10 weeks of each) for the treatment of noncyclic breast pain.
Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic
Completed
Grumental
Phase 4
2006-09-01
The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a
non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute
renal colic.
Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic
Completed
Hadassah Medical Organization
Phase 4
2006-09-01
The purpose of this study is to determine whether Tramadol Hcl is as effective as Voltaren a
non-steroidal antiinflammatory drug, and Dipyrone in amelioration of the pain caused by acute
renal colic.
Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single
drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption
of oral analgesia.
Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis
Completed
Charite University, Berlin, Germany
Phase 4
2008-09-01
This is a randomised, controlled, multi-centre clinical trial on AS patients. Experimental
intervention: continuous (daily) treatment with diclofenac cholestyramine 150 mg (Voltaren
Resinate), divided into 75mg Voltaren twice dailyControl intervention: treatment on-demand
(as needed) with diclofenac-cholestyramine 75 to 150 mg (Voltaren Resinate). The treatment
strategy of the control intervention (on-demand) reflects current clinical practice in AS.
Duration of intervention per patient: 2 years Follow-up per patient: safety assessment 3
months after termination of the trial.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
